{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T09:58:08Z","timestamp":1648979888131},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.transproceed.2010.05.148","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T10:11:51Z","timestamp":1284372711000},"page":"2804-2807","source":"Crossref","is-referenced-by-count":3,"title":["Acute Allograft Renal Failure With Marked Hyperuricemia Developing During Mizoribine Administration: A Case Report With Review of the Literature"],"prefix":"10.1016","volume":"42","author":[{"given":"H.B.","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2010.05.148_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1432-2277.2006.00444.x","article-title":"Prophylactic treatment of antibody-mediated rejection with high-dose mizoribine and pharmacokinetic study","volume":"20","author":"Liu","year":"2007","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2010.05.148_bib2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1399-0012.2006.00522.x","article-title":"Revival of effective and safe high-dose mizoribine for the kidney transplantation","volume":"20","author":"Sugitani","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2010.05.148_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1432-2277.2004.00042.x","article-title":"Potential value of high-dose mizoribine as rescue therapy for ongoing acute humoral rejection","volume":"18","author":"Liu","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2010.05.148_bib4","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1248\/bpb.31.2146","article-title":"Pharmacodynamic parameters of immunosuppressive drugs are not correlated with age, duration of dialysis, percentage of lymphocytes or lymphocyte stimulation index in renal transplant recipients","volume":"31","author":"Sugiyama","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.transproceed.2010.05.148_bib5","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.transproceed.2008.07.069","article-title":"Conversion from mycophenolate mofetil to mizoribine for patients with positive polyomavirus type BK in urine","volume":"40","author":"Funahashi","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.05.148_bib6","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/01.tp.0000296008.08452.4c","article-title":"Japanese experience of ABO-incompatible living kidney transplantation","volume":"84","author":"Tanabe","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.05.148_bib7","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.2165\/00003495-200565180-00004","article-title":"Gout in solid organ transplantation: a challenging clinical problem","volume":"65","author":"Stamp","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2010.05.148_bib8","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/TP.0b013e31818b22ed","article-title":"Gout in renal allograft recipients according to the pretransplant hyperuricemic status","volume":"86","author":"Hern\u00e1ndez-Molina","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.05.148_bib9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/TP.0b013e3181814f5b","article-title":"Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy","volume":"86","author":"Akalin","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.05.148_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.transproceed.2007.11.013","article-title":"Hyperuricemia influences chronic cyclosporine nephropathy","volume":"40","author":"Saglam","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.05.148_bib11","first-page":"161","article-title":"Pharmacological treatment of acute renal failure in intensive care unit patients","volume":"147","author":"Moreau","year":"2005","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.transproceed.2010.05.148_bib12","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.transproceed.2007.03.028","article-title":"Is uric acid a predictive factor for graft dysfunction in renal transplant recipients?","volume":"39","author":"Akgul","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.05.148_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00041552-200401000-00001","article-title":"Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy","volume":"13","author":"Basile","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.transproceed.2010.05.148_bib14","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1097\/01.ASN.0000079785.13922.F6","article-title":"Recent advances in the pathophysiology of ischemic acute renal failure","volume":"14","author":"Bonventre","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2010.05.148_bib15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1523-1755.2004.761_3.x","article-title":"Inflammatory cells in ischemic acute renal failure","volume":"66","author":"Friedewald","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2010.05.148_bib16","doi-asserted-by":"crossref","first-page":"F1150","DOI":"10.1152\/ajprenal.00310.2001","article-title":"Intravital videomicroscopy of peritubular capillaries in renal ischemia","volume":"282","author":"Yamamoto","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.transproceed.2010.05.148_bib17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/BF03401822","article-title":"Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy","volume":"6","author":"Kim","year":"2000","journal-title":"Mol Med"},{"key":"10.1016\/j.transproceed.2010.05.148_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000180438","article-title":"Hyperuricemic nephropathy: pathologic features and factors influencing urate deposition","volume":"14","author":"Klinenberg","year":"1975","journal-title":"Nephron"},{"key":"10.1016\/j.transproceed.2010.05.148_bib19","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.transproceed.2010.05.148_bib20","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","article-title":"Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2","volume":"41","author":"Kanellis","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.transproceed.2010.05.148_bib21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01991","article-title":"Molecular identification of a danger signal that alerts the immune system to dying cells","volume":"425","author":"Shi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.transproceed.2010.05.148_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00074.x","article-title":"Mild hyperuricemia induces severe cortical vasoconstriction and perpetuates glomerular hypertension in normal rats and in experimental chronic renal failure","volume":"67","author":"S\u00e1nchez-Lozada","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2010.05.148_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1523-1755.2000.00168.x","article-title":"A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome","volume":"58","author":"Yoshioka","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2010.05.148_bib24","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/ard.2005.049023","article-title":"Gout, diuretics and the kidney","volume":"65","author":"Pascual","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.transproceed.2010.05.148_bib25","first-page":"115","article-title":"Rasburicase therapy in acute hyperuricemia and renal dysfunction","volume":"147","author":"Ronco","year":"2005","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.transproceed.2010.05.148_bib26","first-page":"61","article-title":"Incidence and pathogenesis of tumor lysis yndrome","volume":"147","author":"Locatelli","year":"2005","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.transproceed.2010.05.148_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2165\/00002018-200831080-00002","article-title":"A benefit-risk assessment of benzbromarone in the treatment of gout","volume":"31","author":"Lee","year":"2008","journal-title":"Drug Saf"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510009024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510009024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T17:01:42Z","timestamp":1559667702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134510009024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0041134510009024"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2010.05.148","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}